تحميل...

ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial

INTRODUCTION: UK guidelines recommend that all early active rheumatoid arthritis (RA) patients are offered combination disease-modifying antirheumatic drugs (DMARDs) and short-term corticosteroids. Anti-citrullinated protein antibody (ACPA)-positive and ACPA-negative RA may differ in their treatment...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Seegobin, Seth D, Ma, Margaret HY, Dahanayake, Chanaka, Cope, Andrew P, Scott, David L, Lewis, Cathryn M, Scott, Ian C
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	BioMed Central 2014
الموضوعات:	Research Article
الوصول للمادة أونلاين:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3979097/ https://ncbi.nlm.nih.gov/pubmed/24433430 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar4439
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial

مواد مشابهة